Cargando…

Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study

Protein-truncating variants can have profound effects on gene function and are critical for clinical genome interpretation and generating therapeutic hypotheses, but their relevance to medical phenotypes has not been systematically assessed. Here, we characterize the effect of 18,228 protein-truncat...

Descripción completa

Detalles Bibliográficos
Autores principales: DeBoever, Christopher, Tanigawa, Yosuke, Lindholm, Malene E., McInnes, Greg, Lavertu, Adam, Ingelsson, Erik, Chang, Chris, Ashley, Euan A., Bustamante, Carlos D., Daly, Mark J., Rivas, Manuel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915386/
https://www.ncbi.nlm.nih.gov/pubmed/29691392
http://dx.doi.org/10.1038/s41467-018-03910-9
_version_ 1783316848105750528
author DeBoever, Christopher
Tanigawa, Yosuke
Lindholm, Malene E.
McInnes, Greg
Lavertu, Adam
Ingelsson, Erik
Chang, Chris
Ashley, Euan A.
Bustamante, Carlos D.
Daly, Mark J.
Rivas, Manuel A.
author_facet DeBoever, Christopher
Tanigawa, Yosuke
Lindholm, Malene E.
McInnes, Greg
Lavertu, Adam
Ingelsson, Erik
Chang, Chris
Ashley, Euan A.
Bustamante, Carlos D.
Daly, Mark J.
Rivas, Manuel A.
author_sort DeBoever, Christopher
collection PubMed
description Protein-truncating variants can have profound effects on gene function and are critical for clinical genome interpretation and generating therapeutic hypotheses, but their relevance to medical phenotypes has not been systematically assessed. Here, we characterize the effect of 18,228 protein-truncating variants across 135 phenotypes from the UK Biobank and find 27 associations between medical phenotypes and protein-truncating variants in genes outside the major histocompatibility complex. We perform phenome-wide analyses and directly measure the effect in homozygous carriers, commonly referred to as “human knockouts,” across medical phenotypes for genes implicated as being protective against disease or associated with at least one phenotype in our study. We find several genes with strong pleiotropic or non-additive effects. Our results illustrate the importance of protein-truncating variants in a variety of diseases.
format Online
Article
Text
id pubmed-5915386
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59153862018-04-27 Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study DeBoever, Christopher Tanigawa, Yosuke Lindholm, Malene E. McInnes, Greg Lavertu, Adam Ingelsson, Erik Chang, Chris Ashley, Euan A. Bustamante, Carlos D. Daly, Mark J. Rivas, Manuel A. Nat Commun Article Protein-truncating variants can have profound effects on gene function and are critical for clinical genome interpretation and generating therapeutic hypotheses, but their relevance to medical phenotypes has not been systematically assessed. Here, we characterize the effect of 18,228 protein-truncating variants across 135 phenotypes from the UK Biobank and find 27 associations between medical phenotypes and protein-truncating variants in genes outside the major histocompatibility complex. We perform phenome-wide analyses and directly measure the effect in homozygous carriers, commonly referred to as “human knockouts,” across medical phenotypes for genes implicated as being protective against disease or associated with at least one phenotype in our study. We find several genes with strong pleiotropic or non-additive effects. Our results illustrate the importance of protein-truncating variants in a variety of diseases. Nature Publishing Group UK 2018-04-24 /pmc/articles/PMC5915386/ /pubmed/29691392 http://dx.doi.org/10.1038/s41467-018-03910-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
DeBoever, Christopher
Tanigawa, Yosuke
Lindholm, Malene E.
McInnes, Greg
Lavertu, Adam
Ingelsson, Erik
Chang, Chris
Ashley, Euan A.
Bustamante, Carlos D.
Daly, Mark J.
Rivas, Manuel A.
Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study
title Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study
title_full Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study
title_fullStr Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study
title_full_unstemmed Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study
title_short Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study
title_sort medical relevance of protein-truncating variants across 337,205 individuals in the uk biobank study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915386/
https://www.ncbi.nlm.nih.gov/pubmed/29691392
http://dx.doi.org/10.1038/s41467-018-03910-9
work_keys_str_mv AT deboeverchristopher medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT tanigawayosuke medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT lindholmmalenee medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT mcinnesgreg medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT lavertuadam medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT ingelssonerik medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT changchris medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT ashleyeuana medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT bustamantecarlosd medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT dalymarkj medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy
AT rivasmanuela medicalrelevanceofproteintruncatingvariantsacross337205individualsintheukbiobankstudy